Aesthetic plastic surgery · 2026
Injectable Filler-Based Chin Augmentation: A Systematic Review of Non-Surgical Volumetric Techniques.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shome Debraj, Bose Debalina, Prabhughate Ashwin, Shah Rasesh, Kapoor Rinky
Аннотация
BACKGROUND: Facial aesthetics are profoundly influenced by the chin, a central feature that shapes harmony, projection, and perceived attractiveness. As demand for minimally invasive cosmetic procedures grows globally, nonsurgical chin augmentation has emerged as a cornerstone in facial contouring. The chin is a small yet powerful determinant of facial harmony. Its retrusion, whether congenital, traumatic, or age-related, can distort balance and undermine self-perception.
PURPOSE: With patients increasingly seeking minimally invasive solutions, this systematic review evaluates injectable volumetric techniques for chin augmentation, with a focus on dermal filler-based interventions, and synthesises current evidence on efficacy, safety, and patient satisfaction.
METHODS: Following PRISMA-E guidelines, a comprehensive search across seven databases (1965-2026) identified clinical studies evaluating injectable fillers (and other eligible injectable volumetric agents) for chin augmentation. Study quality and data diversity were analysed, including I2 heterogeneity.
RESULTS: Eleven eligible studies comprising 876 patients were analysed. Hyaluronic acid fillers predominated, with follow-ups averaging 12.8 months (SD: 7.7). Over 90% of patients reported satisfaction, supported by photographic and patient-reported assessments. Adverse effects were minor and transient, mainly oedema, bruising, and nodularity.
CONCLUSION: Injectable fillers provide effective short-term improvement in chin projection with high patient satisfaction and acceptable safety. However, evidence is heterogeneous and largely non-comparative, limiting conclusions on long-term outcomes. Further controlled studies are required.
NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
PURPOSE: With patients increasingly seeking minimally invasive solutions, this systematic review evaluates injectable volumetric techniques for chin augmentation, with a focus on dermal filler-based interventions, and synthesises current evidence on efficacy, safety, and patient satisfaction.
METHODS: Following PRISMA-E guidelines, a comprehensive search across seven databases (1965-2026) identified clinical studies evaluating injectable fillers (and other eligible injectable volumetric agents) for chin augmentation. Study quality and data diversity were analysed, including I2 heterogeneity.
RESULTS: Eleven eligible studies comprising 876 patients were analysed. Hyaluronic acid fillers predominated, with follow-ups averaging 12.8 months (SD: 7.7). Over 90% of patients reported satisfaction, supported by photographic and patient-reported assessments. Adverse effects were minor and transient, mainly oedema, bruising, and nodularity.
CONCLUSION: Injectable fillers provide effective short-term improvement in chin projection with high patient satisfaction and acceptable safety. However, evidence is heterogeneous and largely non-comparative, limiting conclusions on long-term outcomes. Further controlled studies are required.
NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .